NASDAQ Companies

EDINBURG, Va., Feb. 02, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) will release its fourth quarter and full […]

BOSTON and LONDON, Feb. 02, 2024 (GLOBE NEWSWIRE) — Orchard Therapeutics, a global gene therapy leader recently acquired by Kyowa […]

– Phase 3 open-label, single-arm study conducted in Japan by BridgeBio licensing partner Alexion, AstraZeneca Rare Disease showed consistency with […]

MONTVALE, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be […]

PARSIPPANY, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) — Sio Gene Therapies, Inc. (“Sio”) today announced that it expects to file […]

CAMBRIDGE, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular […]

LATHAM, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions […]

— Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* —— Current Nitisinone market is estimated […]

Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenues increased 14% Full year […]

TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency (EMA) has […]